CAMBRIDGE, Mass., Oct. 26, 2018 (GLOBE NEWSWIRE) — Biogen (Nasdaq: BIIB) and Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced that Biogen presented results at the
(HealthDay)—The first Food and Drug Administration-approved drug containing an ingredient derived from the marijuana plant went on sale Thursday in the United States. Epidiolex is a twice-daily oral
The number of overdose deaths involving methamphetamines and amphetamines in the state of Ohio increased more than 5,000 percent over the course of eight years, according to data
(HealthDay)—A bipartisan bill meant to combat the United States’ opioid abuse epidemic was signed into law Oct. 24 by President Donald Trump. The legislation, which also covers other
In the spring of 2016, while Emily Lindemer was working toward her Ph.D. at MIT, she was also struggling with something closer to home: watching someone she knew
The Harvard Medical School republished a well-worn article in August that recounted a 1985 study in which the U.S. Food and Drug Administration (FDA) looked to pinpoint expiration
In recent years deaths from opioid overdoses have become one of the most common injury-related deaths in North America. The continent also has the highest per capita rate
French health authorities said Tuesday they have approved the use of a muscle relaxant to help treat people addicted to alcohol. The ANSM national drug agency said it
CALGARY, Alberta and SAN DIEGO, Oct. 22, 2018 (GLOBE NEWSWIRE) — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), currently developing pelareorep, an intravenously delivered immuno-oncolytic virus turning cold
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok
